etomoxir has been researched along with glucagon in 2 studies
Studies (etomoxir) | Trials (etomoxir) | Recent Studies (post-2010) (etomoxir) | Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) |
---|---|---|---|---|---|
260 | 8 | 93 | 26,039 | 1,498 | 3,054 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Taegtmeyer, H | 1 |
Hermansen, K; Hong, J; Jeppesen, PB; Nordentoft, I | 1 |
2 other study(ies) available for etomoxir and glucagon
Article | Year |
---|---|
Cardiac metabolism as a target for the treatment of heart failure.
Topics: Acetanilides; Animals; Dogs; Energy Metabolism; Epoxy Compounds; Fatty Acids; Forecasting; Glucagon; Glucagon-Like Peptide 1; Glucose; Heart Failure; Humans; Insulin Resistance; Myocardium; Peptide Fragments; Piperazines; Protein Precursors; Ranolazine; Recombinant Proteins | 2004 |
Fatty acid-induced effect on glucagon secretion is mediated via fatty acid oxidation.
Topics: Animals; Carnitine O-Palmitoyltransferase; DNA; Epoxy Compounds; Fatty Acids; Gene Expression Regulation; Glucagon; Glucagon-Secreting Cells; Mice; Oleic Acid; Oxidation-Reduction; Palmitic Acid; Triglycerides; Tumor Cells, Cultured | 2007 |